| |
Survivor (n = 19)
|
Non-survivor (n = 11)
|
p value
|
|---|
|
Age (years, mean ± SD)
|
58.1 ± 16.9
|
66.1 ± 16.2
|
0.215
|
|
Gender (% of male)
|
57.9
|
54.5
|
–
|
|
SAPS II (mean ± SD)
|
51.65 ± 19.23
|
73.69 ± 13.85
|
0.002*
|
|
SOFA (mean ± SD)
|
8.18 ± 3.52
|
12.29 ± 1.43
|
<0.001**
|
|
PT (s) (median, IQR)
|
13.96 (13.11–15.13)
|
14.48 (13.64–1.69)
|
0.127
|
|
aPTT (s) (mean ± SD)
|
55.18 ± 10.32
|
70.46 ± 22.92
|
0.020*
|
|
Platelet count (×10) (mean ± SD)
|
209.3 ± 83.1
|
148.9 ± 72.9
|
0.055
|
|
White blood cell count (mean ± SD)
|
14.08 ± 8.61
|
17.63 ± 9.04
|
0.293
|
|
CRP (mean ± SD)
|
231.35 ± 99.73
|
226.79 ± 106.89
|
0.928
|
|
HK (mean ± SD)
|
0.284 ± 0.032
|
0.282 ± .021
|
0.832
|
|
Hb (mean ± SD)
|
5.75 ± 0.65
|
5.74 ± 0.48
|
0.952
|
|
Procalcitonin (median, IQR)
|
2.40 (1.36–14.93)
|
2.73 (1.12–7.99)
|
0.846
|
|
MVs, phosphatidylserine (nM) (mean ± SD)
|
18.69 ± 6.13
|
16.63 ± 6.33
|
0.388
|
|
TF (pg/ml) (mean ± SD)
|
269.75 ± 171.47
|
325.22 ± 169.82
|
0.399
|
- Data are expressed as mean ± SD or median and 25 to 75 % interquartile range (IQR) *p < 0.05, **p < 0.001
